US Stock MarketDetailed Quotes

ALNY Alnylam Pharmaceuticals

Watchlist
  • 237.830
  • +1.130+0.48%
Close Jul 19 16:00 ET
30.08BMarket Cap-90087P/E (TTM)

Alnylam Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Alnylam Pharmaceuticals Earnings Date

Currency: USD

Period

Q2 FY2024 Estimates

Aug 1, 2024

Revenue(YoY)

446.20M

+39.98%
EPS(YoY)

-1.09

+50.61%
Analyst Rating

Buy

Jul 22, 2024

Alnylam Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 22 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 460.089M--
Aug 1, 20242024/Q2-- / 446.199M--
May 2, 20242024/Q1494.333M / 426.730M--
Feb 15, 20242023/Q4439.718M / 442.296M--
Nov 2, 20232023/Q3750.530M / 394.549M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 460.089M--
Aug 1, 20242024/Q2-- / 446.199M--
May 2, 20242024/Q1494.333M / 426.730M--
Feb 15, 20242023/Q4439.718M / 442.296M--
Nov 2, 20232023/Q3750.530M / 394.549M--

Unlock Free Earnings Estimates

Alnylam Pharmaceuticals Earnings Reports

  • Alnylam Pharmaceuticals | 10-Q: Quarterly report

    May 2 08:23 ET

  • Alnylam Pharmaceuticals | 10-K: Annual report

    Feb 15 16:29 ET

  • Alnylam Pharmaceuticals | 10-Q: Q3 2023 Earnings Report

    Nov 2, 2023 08:22 ET

  • Alnylam Pharmaceuticals | 10-Q: Q2 2023 Earnings Report

    Aug 3, 2023 08:18 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jul 22, 2024

    Buy

    • Buy

      66.67%

    • Hold

      33.33%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg